Fox Chase Cancer Center
Fox Chase Cancer Center
Explore linked clinical trials.58 results ยท Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2026-10-02 | NCT07854769 | |
| Penn Medicine Biobank Return of Results Program | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cancer, cardiovascular disorder, hereditary disease, neoplasm | Active, not recruiting | Not applicable | 2026-10-02 | NCT06089954 | |
| Prehabilitation in High-risk Oncologic Surgery | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal cancer, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric cancer, gastric neoplasm, gonadal disorder, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, stomach disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not applicable | 2026-09-21 | NCT07638410 | |
| Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning. | Care Delivery; Geriatric Assessment; Geriatrics | Recruiting | Not applicable | 2026-09-21 | NCT06652347 | |
| Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II) | cancer, neoplasm | Active, not recruiting | Phase 3 | 2026-09-21 | NCT05454280 | |
| Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 1 | 2026-09-21 | NCT05274048 | |
| A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Active, not recruiting | Phase 2 | 2026-09-21 | NCT04506554 | |
| Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Active, not recruiting | Not applicable | 2026-09-21 | NCT02968732 | |
| Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy | Immune-mediated Hepatitis; Immune-related Adverse Event | Recruiting | Phase 2 | 2026-09-17 | NCT07663422 | |
| Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT07043972 | |
| Testing Gene PilotLX With Latinx Cancer Patients | cancer, neoplasm | Active, not recruiting | Not applicable | 2026-09-02 | NCT06476938 | |
| A Genotype-Phenotype Urothelial Cancer Registry | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, malignant renal pelvis neoplasm, neoplasm, ureter cancer, ureteral disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Not stated | 2026-08-24 | NCT00902590 | |
| Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients | Hyperphagia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, cancer, neoplasm | Recruiting | Not applicable | 2026-08-20 | NCT07776704 | |
| Genetic Information for Families After Tumor Testing Study | cancer, neoplasm | Enrolling by invitation | Not applicable | 2026-07-29 | NCT07517666 | |
| Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors | Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoid tumor, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, renal cell carcinoma, urinary system disorder | Recruiting | Phase 2 | 2026-07-28 | NCT05263050 | |
| Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Not applicable | 2026-07-06 | NCT06030011 | |
| Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) | cancer, neoplasm | Recruiting | Not applicable | 2026-06-12 | NCT07454499 | |
| Communication About Sexual Health in Gynecologic Cancer | Gynecologic Cancers | Recruiting | Not applicable | 2026-06-02 | NCT06904339 | |
| Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Recruiting | Phase 2 | 2026-05-22 | NCT05800600 | |
| Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-05-22 | NCT05800587 | |
| Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2026-05-22 | NCT05800574 | |
| Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Early phase 1 | 2026-05-22 | NCT05498792 | |
| PHL Treatment in Pancreatic Cancer | pancreatic ductal adenocarcinoma | Active, not recruiting | Early phase 1 | 2026-05-22 | NCT05365893 | |
| Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Not applicable | 2026-05-22 | NCT04452357 | |
| Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Active, not recruiting | Not stated | 2026-05-22 | NCT04055753 |